Compounds of Formula 1 ##STR00001## and pharmaceutically acceptable salts
thereof, wherein m, Ar, R.sup.1, R.sup.2, and R.sup.3 are as defined
herein. The invention also provides methods for preparing, coompositions
comprising, and methods for using compounds of Formula 1 for treatment of
central nervous system disorders.